Scholarly Index
Andrea B. Apolo
National Cancer Institute; 8,656 total citations; 291 total publications; best world rank #67
National Cancer Institute
8,656Total citations
291Total publications
45H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Bladder and Urothelial Cancer Treatments | Lifetime | 367 | US 191 | 98.48 |
| Urinary and Genital Oncology Studies | Lifetime | 233 | US 131 | 98.31 |
| Cancer Immunotherapy and Biomarkers | Lifetime | 937 | US 454 | 98.08 |
| Renal cell carcinoma treatment | Lifetime | 613 | US 325 | 97.55 |
| Multiple and Secondary Primary Cancers | Lifetime | 373 | US 160 | 96.31 |
| Renal cell carcinoma treatment | 2021-2025 | 67 | US 26 | 98.82 |
| Bladder and Urothelial Cancer Treatments | 2021-2025 | 112 | US 49 | 98.54 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 619 | US 231 | 97.65 |
| Urinary and Genital Oncology Studies | 2021-2025 | 101 | US 42 | 97.49 |
| Multiple and Secondary Primary Cancers | 2021-2025 | 69 | US 29 | 92.80 |
| Economic and Financial Impacts of Cancer | 2021-2025 | 326 | US 205 | 91.43 |